E25.0 E28.3 E29.1 E29.9 E34.5 K43.6 Q51.8 Q56 Q55.8 Q64.1 Q87.1 Q87.8 Q96 Q97.3 Q98 Q99.0 Q99.1
Conditions
Interventions
Group 1: People with differences/disorders of sex development (DSD) according to the Chicago classification 2005
inclusion into clinical registry and completion of standardised questionnaires capturing socio-demographic items, and measuring quality of life and satisfaction with care, immediately/ 6 and 12 months
Sponsors
Universitätsklinikum Schleswig-HolsteinKlinik für Kinder- und JugendmedizinSektion Pädiatrische Endokrinologie und Diabetologie
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosis of DSD according to Chicago Classification 2005 OR - overt genital ambiguity - apparent female genitalia with an enlarged clitoris, posterior labial fusion, or an inguinal/labial mass - apparent male genitalia with bilateral undescended testes, micropenis, isolated perineal hypospadias, or mild hypospadias with undescended testes - discordance between genital appearance and a prenatal karyotype - female phenotype with pubertal virilization and/or primary amenorrhea and/or no thelarche - male phenotype with pubertal hypovirilization AND written consent to participate in the study
Exclusion criteria
Exclusion criteria: - acquired hypogonadotropic hypogonadism - no written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Structural and process quality of care | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome quality | — |
Countries
Germany
Contacts
Public ContactUlla Döhnert
Universitätsklinikum Schleswig-HolsteinKlinik für Kinder- und JugendmedizinSektion für Pädiatrische Endokrinologie und Diabetologie
Outcome results
None listed